We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.61B
AUM Growth
+$447M
Cap. Flow
+$533M
Cap. Flow %
33.15%
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595

Top Sells

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$4.13M
2
NVDA icon
NVIDIA
NVDA
+$4.12M
3
PFE icon
Pfizer
PFE
+$4.01M
4
LNG icon
Cheniere Energy
LNG
+$3.83M
5
HOLX
Hologic
HOLX
+$3.1M

Sector Composition

Rank Sector Weight
1 Financials 13.44%
2 Technology 13.16%
3 Healthcare 12.56%
4 Industrials 12.44%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSA icon
2076
Public Storage
PSA
$61.3B
-1,798
Closed -$467K
PSEC icon
2077
Prospect Capital
PSEC
$1.17B
-174,627
Closed -$452K
PSN icon
2078
Parsons
PSN
$5.08B
-5,822
Closed -$360K
PTCT icon
2079
PTC Therapeutics
PTCT
$6.12B
-10,754
Closed -$817K
PTEN icon
2080
Patterson-UTI
PTEN
$3.76B
-173,169
Closed -$1.06M
PYPL icon
2081
PayPal
PYPL
$50.5B
-4,047
Closed -$236K
PZG icon
2082
Paramount Gold Nevada
PZG
$124M
-11,338
Closed -$14K
QGEN icon
2083
Qiagen
QGEN
$8.72B
-4,655
Closed -$209K
QNCX icon
2084
Quince Therapeutics
QNCX
$29.5M
-560
Closed -$375K
QQEW icon
2085
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.82B
-2,065
Closed -$293K
RAPT
2086
DELISTED
RAPT Therapeutics
RAPT
-22,944
Closed -$777K
RCKT icon
2087
Rocket Pharmaceuticals
RCKT
$394M
-36,836
Closed -$129K
RCUS icon
2088
Arcus Biosciences
RCUS
$3.64B
-32,692
Closed -$779K
RDCM icon
2089
Radcom
RDCM
$169M
-11,605
Closed -$152K
REI icon
2090
Ring Energy
REI
$339M
-604,791
Closed -$526K
REPL icon
2091
Replimune Group
REPL
$1.01B
-29,147
Closed -$283K
RGCO icon
2092
RGC Resources
RGCO
$228M
-11,493
Closed -$245K
RGP icon
2093
Resources Connection
RGP
$145M
-12,822
Closed -$65K
RIOT icon
2094
Riot Platforms
RIOT
$7.76B
-12,359
Closed -$157K
RITM icon
2095
Rithm Capital
RITM
$5.69B
-111,473
Closed -$1.22M
RLYB icon
2096
Rallybio
RLYB
$85.8M
-2,413
Closed -$13K
RNAM
2097
DELISTED
Avidity Biosciences
RNAM
-8,284
Closed -$598K
RNAC icon
2098
Cartesian Therapeutics
RNAC
$268M
-77,227
Closed -$557K
ROAD icon
2099
Construction Partners
ROAD
$6.77B
-4,285
Closed -$465K
ROBT icon
2100
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$774M
-4,877
Closed -$253K

Similar funds

GSA Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
  • GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
  • GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
  • GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
  • GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.